Coumarin derivatives: an updated patent review (2012 – 2014)

Bibliography

• Borges F, Roleira F, Milhazes N, et al. Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem 2005;12(8):887-916
   PubMed Web of Science ®Google Scholar
• Kontogiorgis C, Detsi A, Hadjipavlou-Litina D. Coumarin-based drugs: a patent review (2008 – present). Expert Opin Ther Pat 2012;22(4):437-54
   PubMed Web of Science ®Google Scholar
• Xu P, Peng Y, Wang C, et al. inventors Peking University, Peop. Rep. China. assignee. Coumarin derivatives as mitogen-activated and extracellular signal-regulated kinase inhibitor, and their preparation. CN102964326A; 2013
   Google Scholar
• Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK cascade for the treatment of cancer. Oncogene 2007;26(22):3291-310
   PubMed Web of Science ®Google Scholar
• De Luca A, Maiello MR, D’Alessio A, et al. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets 2012;16(S2):S17-27
   Google Scholar
• Wang C, Zhang H, Xu F, et al. Substituted 3-Benzylcoumarins as Allosteric MEK1 Inhibitors: design, Synthesis and Biological Evaluation as Antiviral Agents. Molecules 2013;18(5):6057-91
   Google Scholar
• Yuan J, Song F, Xie X, et al. inventors; Northwest Normal University, Peop. Rep. China. assignee. Coumarins polymer with anti-tumor activity and its preparation method. CN103012671A; 2013
   Google Scholar
• Liu Q, Duan H, Luan J, et al. Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells. Cytotechnology 2009;59(3):211-17
   PubMed Web of Science ®Google Scholar
• Zhang G, Zhang Y. inventors; Yantai University, Peop. Rep. China. assignee. Application of DTClC and DTBrC in preparing drug for preventing and treating cancer. CN103110621A; 2013
   Google Scholar
• Ma L, Zhang B, Chen Y, et al. inventors; Beijing Hanmi Pharmaceutical Co., Ltd., Peop. Rep. China. assignee. Coumarin compound useful in treatment of cancer and its preparation. CN103172606A; 2013
   Google Scholar
• Li R, Wei Y. inventors; Sichuan University, Peop. Rep. China. assignee. Five-membered urea ring-fused coumarin derivatives as PI3K/mTOR inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancer. CN103254203A; 2013
   Google Scholar
• Serra V, Markman B, Scaltriti M, et al. NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations. Cancer Res 2008;68(19):8022-30
   PubMed Web of Science ®Google Scholar
• Wei C, Gao N. inventors; Shanxi University, Peop. Rep. China. assignee. Preparation of coumarin derivative as antitumor agent. CN103275071A; 2013
   Google Scholar
• Matsunaga T, Nishinaga M, Saito T, Osada H; Kanazawa University, Japan. assignee. Nucleotide excision repair inhibitor, antitumor agent, and UV therapy enhancer. JP2013221018A; 2013
   Google Scholar
• Chen Y, He F, Ma C, et al. inventors; Third Military Medical University, PLA, Peop. Rep. China. assignee. Coumarin skeleton polycyclic compound useful in treatment of cancer and its preparation. CN103408530A; 2013
   Google Scholar
• Zou J, Cao X, Li D, Pan X. inventors; Soochow University, Peop. Rep. China. assignee. Method for preparing 3-trifluoromethyl coumarin derivative. CN103554074A; 2014
   Google Scholar
• Cao X-H, Pan X, Zhou P-J, et al. Manganese(iii)-mediated direct Csp2-H radical trifluoromethylation of coumarins with sodium trifluoromethanesulfinate. Chem Commun 2014;50(25):3359-62
   Google Scholar
• Zhang X, Yang Y, Zhao M, et al. A class of Trp-Trp-AA-OBzl: synthesis, in vitro anti-proliferation/in vivo anti-tumor evaluation, intercalation-mechanism investigation and 3D QSAR analysis. Eur J Med Chem 2011;46(8):3410-19
   Google Scholar
• Zhang J, Wang X, Li H, Xu G. inventors; Capital Medical University, Peop. Rep. China. assignee. Preparation of peptide containing coumarin derivatives for treatment of cancer. CN102898502A; 2013
   Google Scholar
• Ma L, Zhang B, Li M, et al. inventors; Beijing Hanmi Pharmaceutical Co., Ltd., Peop. Rep. China. assignee. Preparation of coumarin derivatives useful in treating tumor and/or inflammation. WO2012171488A1; 2012
   Google Scholar
• Li R, Zhao Y, Song X, Wei Y. inventors; Sichuan University, Peop. Rep. China. assignee. 4-(1,2,3-triazol-1-yl)coumarin derivatives and its preparation method and application. CN102746281A; 2012
   Google Scholar
• Zhang W, Li Z, Zhou M, et al. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents. Bioorg Med Chem Lett 2014;24(3):799-807
   PubMed Web of Science ®Google Scholar
• Combes S, Daras E, Peyrot V, et al. inventors; Universite de Marseille, Fr. assignee. Derivatives of 4-arylcoumarin and 4-arylquinoline as inhibitors of drug transporters and their preparation and use as antineoplastic agents. WO2012136910A1; 2012
   Google Scholar
• Wind NS, Holen I. Multidrug resistance in breast cancer: from in vitro models to clinical studies. Int J Breast Cancer 2011;2011:967419
   PubMedGoogle Scholar
• Song Z, Jin Y, Li D, Jiang D. inventors; Jilin University, Peop. Rep. China. assignee. 3-Aryl-8-allyl-7-hydroxy(methoxy)coumarins as antitumor drugs and their preparation, pharmaceutical compositions and use in the treatment of cancer. CN102675273A; 2012
   Google Scholar
• Liu Z-H, Li D-J, Jiang D, et al. Design, synthesis and antitumor activity in vitro of a series of 3-arylcoumarins. Chem Res Chin Univ 2013;29(6):1125-8
   Google Scholar
• Fortin S, Bérubé G. Advances in the development of hybrid anticancer drugs. Expert Opin Drug Discov 2013;8(8):1029-47
   PubMed Web of Science ®Google Scholar
• Sashidhara KV, Kumar A, Kumar M, et al. inventors; Council of Scientific & Industrial Research, India., assignee. Coumarin-chalcones as anticancer agents. US20130210909A1; 2013
   Google Scholar
• Sashidhara KV, Kumar A, Kumar M, et al. Synthesis and in vitro evaluation of novel coumarin–chalcone hybrids as potential anticancer agents. Bioorg Med Chem Lett 2010;20(24):7205-11
   PubMed Web of Science ®Google Scholar
• Zhiwei C, Weike S, Jianhao B, Xiaojing Y. inventors; Zhejiang University of Science and Technology, China., assignee. Quinoline coumarin derivate and preparation method and application thereof. CN102584841A; 2012
   Google Scholar
• Ren F, Chen S, Li L, et al. inventors; NCPC New Drug Research and Development Co., Ltd., Peop. Rep. China. assignee. Coumarin-like compounds, preparation method and application thereof. CN102532084A; 2012
   Google Scholar
• Supuran C, Dedhar S, Carta F, et al. inventors; Metasignal Therapeutics Inc., Can.; Universite Montpellier 2 Sciences et Techniques; CNRS - Dire. assignee. Carbonic anhydrase inhibitors with antimetastatic activity. WO2012070024A1; 2012
   Google Scholar
• Wei Y, Ma C, Hattori M, et al. inventors; Guiyang College of Traditional Chinese Medicine, Peop. Rep. China. assignee. Coumarins application and its extraction method from daphne papyracea. CN103027909A; 2013
   Google Scholar
• Yuan Y, Xu J. inventors; Sun Yat-Sen University, Peop. Rep. China. assignee. Benzo alpha-pyrone compound as gamma-type human herpesvirus resisting medicine. CN103070858A; 2013
   Google Scholar
• Zhang P, Yang Y, Wang Z, et al. inventors; Zhejiang Academy of Medical Sciences, Peop. Rep. China. assignee. Preparation of stilbene derivative as selective estrogen receptor modulator. CN103058832A; 2013
   Google Scholar
• Li G, Huang J, Meng H, et al. inventors; Peop. Rep. China. assignee. Sesquiterpene coumarin and sesquiterpene chromone compounds extracted from Ferula ferulaeoides. CN103113382A; 2013
   Google Scholar
• He H, He L, Wang T, et al. inventors; Xi’an Jiaotong University, Peop. Rep. China. assignee. Pyrrole-coumarin Compounds Useful in Treatment of Hypertension and Their Preparation. CN103408554A; 2013
   Google Scholar
• Denisenko PP, Tarasenko AA, inventors; Russia. assignee. Chloropropoxy derivatives of 7-oxo-coumarin, having tranquilizing and hepatoprotective action. RU2452732C2; 2012
   Google Scholar
• Chen Y, Yu Y, Wang W, et al. inventors; Changchun University of Science and Technology, Peop. Rep. China. assignee. Fraxinus mandshurica extract for treating rheumatoid arthritis. CN103110700A; 2013
   Google Scholar
• Naiki M, Okada T, Sawada K, Ogino T. inventors; Nippon Zoki Pharmaceutical Co., Ltd., Japan. assignee. Coumarin derivatives and pharmaceutical compositions containing them for treatment of arthropathy. WO2014046224A1; 2014
   Google Scholar
• Wu L, Zhang J, Zeng J. inventors; Gannan Medical University, Peop. Rep. China. assignee. Process for synthesis of murrayone and its application in preventing and treating osteoarthritis. CN102603694A; 2012
   Google Scholar
• Chen J, Xie X, Han S, Zhang F. inventors; Zhejiang University, Peop. Rep. China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences. assignee. Preparation of 3-substituted coumarin derivatives useful for preventing/treating the diseases caused by CB2 receptor. CN103265517A; 2013
   Google Scholar
• Pertwee RG. The pharmacology of cannabinoid receptors and their ligands: an overview. Int J Obes 2006;30(S1):S13-18
   Google Scholar
• Liu H, Ye X, Duan Y, et al. inventors; Zhengzhou University, Peop. Rep. China. assignee. Preparation of 1,2,3-triazolyl dithiocarbamate compounds containing coumarin mother nucleus as histone demethylase LSD1 inhibitors. CN103319466A; 2013
   Google Scholar
• Ye X-W, Zheng Y-C, Duan Y-C, et al. Synthesis and biological evaluation of coumarin-1,2,3-triazole-dithiocarbamate hybrids as potent LSD1 inhibitors. Med Chem Commun 2014;5(5):650-4
   Google Scholar
• Somesh S, Ashish S, Kavita S, Sandip K. inventors; Piramal Enterprises Ltd., India. assignee. A method of treatment for acne and an anti-acne formulation comprising a coumarin compound. WO2013164841A2; 2013
   Google Scholar
• Goettig P, Magdolen V, Brandstetter H. Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs). Biochimie 2010;92(11):1546-67
   PubMed Web of Science ®Google Scholar
• Pampalakis G, Sotiropoulou G. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim Biophys Acta 2007;1776(1):22-31
   PubMed Web of Science ®Google Scholar
• Reboud-Ravaux M, Yerroum-El Amri C, Tan X, et al. inventors; Universite Pierre et Marie CURIE Paris 6, Fr. assignee. Use of coumarin derivatives for the preparation of drugs for treating skin diseases. US20140148480A1; 2014
   Google Scholar
• Liu T, Mu Q, Jibens S, Xie H. inventors; Fudan University, Peop. Rep. China. assignee. Coumarin-series natural product, and its preparation method and application. CN103387582A; 2013
   Google Scholar
• Damu GLV, Wen Q, Cui S, et al. inventors; Southwest University, Peop. Rep. China. assignee. Method for preparation of coumarin triazole and its application. CN102796085A; 2012
   Google Scholar
• Davies PO. Multi-drug-resistant tuberculosis. In: Madkour MM, editor. Tuberculosis. Springer; Berlin, Heidelberg: 2004. p. 809-37
   Google Scholar
• Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet2010;375(9728):1830-43
   PubMed Web of Science ®Google Scholar
• Schinkovitz A, Gibbons S, Stavri M, et al. Ostruthin: an antimycobacterial coumarin from the roots of Peucedanum ostruthium. Planta Med 2003;69(4):369-71
   PubMed Web of Science ®Google Scholar
• Parmar VS, Prasad AK, Raj HG, et al. inventors; University of Delhi, India; Vallabhbhai Patel Chest Institute. assignee. Coumarin compounds for the treatment of mycobacterial infections. WO2012137224A1; 2012
   Google Scholar
• Reece RJ, Maxwell A. DNA gyrase: structure and function. Crit Rev Biochem Mol Biol 1991;26(3-4):335-75
   PubMed Web of Science ®Google Scholar
• Anderle C, Stieger M, Burrell M, et al. Biological activities of novel gyrase inhibitors of the aminocoumarin class. Antimicrob Agents Chemother 2008;52(6):1982-90
   Google Scholar
• Flatman RH, Eustaquio A, Li SM, et al. Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesis. Antimicrob Agents Chemother 2006;50(4):1136-42
   Google Scholar
• Heide L, Alt S. inventors; Eberhard-Karls-Universitaet Tuebingen, Germany. assignee. New antibiotics consisting of a gyrase inhibitor with a catechin structural unit for improved up-take by siderophore transporters into the cell, and a process for their production and use as drugs. DE102010055566A1; 2012
   Google Scholar
• Alt S, Burkard N, Kulik A, et al. An Artificial Pathway to 3,4-Dihydroxybenzoic Acid Allows Generation of New Aminocoumarin Antibiotic Recognized by Catechol Transporters of E. coli. Chem Biol 2011;18(3):304-13
   Google Scholar
• Möllmann U, Heinisch L, Bauernfeind A, et al. Siderophores as drug delivery agents: application of the “Trojan Horse” strategy. Biometals 2009;22(4):615-24
   PubMed Web of Science ®Google Scholar
• Liu G, Chen N, Sun M, et al. inventors; Institute of Materia Medica, Chinese Academy of Medical Sciences, Peop. Rep. China. assignee. Preparation of coumarin derivative and application for preventing and treating serious brain disease. CN103450134A; 2013
   Google Scholar
• Liu G, Chen N, Sun M, et al. inventors; Institute of Materia Medica, Chinese Academy of Medical Sciences, Peop. Rep. China. assignee. Application of coumarin derivative in preventing/treating major brain diseases. CN103446154A; 2013
   Google Scholar
• Li G, Wang D, Sun M, et al. Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice. J Med Chem 2010;53(4):1741-54
   Google Scholar
• Song XY, Hu JF, Sun MN, et al. IMM-H004, a novel coumarin derivative compound, protects against amyloid beta-induced neurotoxicity through a mitochondrial-dependent pathway. Neuroscience 2013;242:28-38
   Web of Science ®Google Scholar
• Song X-Y, Hu J-F, Sun M-N, et al. IMM-H004, a novel coumarin derivative compound, attenuates the production of inflammatory mediatory mediators in lipopolysaccharide-activated BV2 microglia. Brain Res Bull 2014;106:30-8
   Google Scholar
• Pan Y, Yang S, Han L, Teng B. inventors; Peking University, Peop. Rep. China. assignee. Preparation and application of 4-methyl-7-hydroxy-8-(1-hydroxyethyl)coumarin. CN102584763A; 2012
   Google Scholar
• Sun H. inventor; Beijing Hexin Feifan Biotechnology Co., Ltd., Peop. Rep. China. assignee. Substrate, reagent and method for determining activity of N-acetyl-α-glucosaminidase. CN103484525A; 2014
   Google Scholar
• Chao J, Zhang Y, Zhang Y. inventors; Shanxi University, Peop. Rep. China. assignee. Coumarin derivative, preparation method and application. CN103570701A; 2014
   Google Scholar
• Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001;44(2):129-46
   PubMed Web of Science ®Google Scholar
• Hyogo H, Yamagishi S-I. Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease. Curr Pharm Des 2008;14(10):969-72
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Vannucci SJ, Yan SSD, et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005;15(7):16R-28R
   PubMed Web of Science ®Google Scholar
• Vistoli G, De Maddis D, Cipak A, et al. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 2013;47(S1):3-27
   Google Scholar
• Zheng Z, Zhu Q, Shi X, et al. inventors; Guangzhou Consun Pharmaceutical Research Co., Ltd., Peop. Rep. China. assignee. Application of coumarin derivative in preparation of AGEs formation inhibitor. CN102846598A; 2013
   Google Scholar
• Li F, Hu J, Wang J, Han B. inventors; China Tobacco Guangdong Industrial Co., Ltd., Peop. Rep. China. assignee. A coumarin derivative as antioxidant and its preparation. CN103601711A; 2014
   Google Scholar
• Li F, Hu J, Wang J. inventors; China Tobacco Guangdong Industrial Co., Ltd., Peop. Rep. China. assignee. Coumarin derivative as antioxidant and its preparation. CN103601710A; 2014
   Google Scholar
• Yang S, Pan Y, Han L, et al. inventors; Huaihai Institute of Technology, Peop. Rep. China. assignee. Method for preparation of coumarin derivative and its application. CN102775374A; 2012
   Google Scholar
• Lee YS, Ryu JH, Nam SO, Park DH. inventors; Kyunghee University, Industry Academic Cooperation Foundation, S. Korea. assignee. Coumarin derivative as acetylcholinesterase inhibitor and method for the preparation thereof. KR2012040596A; 2012
   Google Scholar
• Rollinger JM, Hornick A, Langer T, et al. Acetylcholinesterase Inhibitory Activity of Scopolin and Scopoletin Discovered by Virtual Screening of Natural Products. J Med Chem 2004;47(25):6248-54
   PubMed Web of Science ®Google Scholar
• Nam SO, Park DH, Lee YH, et al. Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors. Bioorg Med Chem 2014;22(4):1262-7
   Google Scholar
• Kulkarni MV, Kulkarni GM, Lin CH, Sun CM. Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents. Curr Med Chem 2006;13(23):2795-818
   Google Scholar
• Sahoo SS, Shukla S, Nandy S, Sahoo HB. Synthesis of novel coumarin derivatives and its biological evaluations. Eur J Exp Biol 2012;2(4):899-908
   Google Scholar
• Reddy KR, Mamatha R, Babu MS, et al. Synthesis and Antimicrobial Activities of Some Triazole, Thiadiazole, and Oxadiazole Substituted Coumarins. J Heterocycl Chem 2014;51(1):132-7
   Google Scholar
• Smyth T, Ramachandran VN, Smyth WF. A study of the antimicrobial activity of selected naturally occurring and synthetic coumarins. Int J Antimicrob Agents 2009;33(5):421-6
   PubMed Web of Science ®Google Scholar
• Jain P, Joshi H. Coumarin: chemical and Pharmacological Profile. J App Pharm Sci 2012;2(6):236-40
   Google Scholar
• Burke AS, FitzGerald GA. Analgesic-antipyretic and antiinflammatory agents; pharmacotherapy of Gout. In: Brunton L, Lazo J, Parker K, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 11 edition. McGraw-Hill Education, New York; 2005. p. 1211-18
   Google Scholar
• Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr Pharm Des 2004;10(30):3813-33
   PubMed Web of Science ®Google Scholar
• Floc’h F. Coumarin in plants and fruits: implication in perfumery. Perf Flav 2002;27:32-6
   Google Scholar
• Lacy A, O’Kennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des 2004;10(30):3797-811
   PubMed Web of Science ®Google Scholar